Cardiology
Mitral Regurgitation
A decision-focused approach to confirming severity, separating primary from secondary mitral regurgitation, selecting repair versus transcatheter therapy, and identifying patients whose ventricular remodeling or heart failure burden warrants multidisciplinary valve intervention.
First decision
Establish mechanism before assigning a treatment pathway
The first actionable distinction is primary versus secondary MR.
Use transthoracic echocardiography (TTE) to define leaflet motion, annular and subvalvular anatomy, LV size and systolic function, left atrial size, and pulmonary pressure estimates. Describe leaflet motion with the Carpentier classification because this links the observed jet to valve pathology and repair strategy. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Classify MR as primary when the initiating lesion is within the valve apparatus, such as degenerative leaflet prolapse or flail and chordal abnormality. Classify MR as secondary when LV disease causes leaflet malcoaptation; this distinction is essential because natural history, severity interpretation, and treatment choices differ. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Obtain transesophageal echocardiography (TEE) when TTE does not adequately define leaflet or chordal anatomy, when repairability is uncertain, or when transcatheter edge-to-edge repair (TEER) is being considered. Dedicated review of echocardiographic and cross-sectional imaging by experienced valve clinicians should precede a multidisciplinary decision on intervention. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Primary MR: identify the abnormal leaflet, segment, chordae, and direction of the jet to determine surgical repair feasibility. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Secondary MR: define the underlying LV phenotype and involve a heart failure specialist in the multidisciplinary assessment. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
When MR mechanism, severity, symptoms, and ventricular response are discordant, use complementary imaging rather than relying on one linear LV measurement or ejection fraction alone. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
| MR phenotype | Key imaging finding | Immediate next action |
|---|---|---|
| Primary MR | Abnormality of the mitral valve apparatus; use Carpentier leaflet-motion classification to define mechanism. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart | Assess likelihood of durable surgical repair and obtain TEE when anatomy is insufficiently defined on TTE. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ... |
| Secondary MR | MR arising from LV disease and leaflet malcoaptation rather than intrinsic valve disease. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart | Integrate heart failure expertise, optimize the heart failure pathway, and assess candidacy for valve intervention through a multidisciplinary team. BMJ+1BMJGetting the best from the Heart Team: guidance for cardiac ...Oxford AcademicThe management of secondary mitral regurgitation in patients ... |
| Indeterminate or discordant MR | Incongruent qualitative jet findings, quantitative measures, chamber remodeling, or clinical status. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical Trial | Review image quality and use three-dimensional echocardiography or CMR when additional anatomic or volumetric clarification will alter management. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical Trial |
Quantification
Grade MR with an integrated echocardiographic assessment
Quantitative thresholds must be interpreted in the context of mechanism and jet geometry.
For severe MR, integrate vena contracta, effective regurgitant orifice area (EROA), regurgitant volume, regurgitant fraction, jet characteristics, pulmonary venous flow, and ventricular response rather than making a decision from any isolated metric. The American Society of Echocardiography threshold cited for severe MR includes vena contracta greater than 0.7 cm, regurgitant volume greater than 60 mL, and regurgitant fraction greater than 50%. AHA JournalsAHA JournalsPercutaneous Interventions for Secondary Mitral Regurgitation
For holosystolic primary MR, EROA of at least 40 mm² and regurgitant volume of at least 60 mL are conventional severe-MR thresholds. Quantitative Doppler data likewise identified severe MR thresholds of 60 mL regurgitant volume, 50% regurgitant fraction, and 40 mm² effective orifice area. AHA Journals+1AHA JournalsGrading of Mitral Regurgitation by Quantitative Doppler ...ACCClinical Trial
Secondary MR requires special caution. An EROA of at least 20 mm² or regurgitant volume of at least 30 mL has been used as a severe-MR threshold in guideline-based frameworks, but PISA can substantially underestimate severity when the regurgitant orifice is elliptical or multiple jets are present. Consider three-dimensional EROA assessment when this limitation changes referral or procedural decisions, recognizing that three-dimensional imaging may overestimate actual EROA. ACCACCClinical Trial
Interpret PISA cautiously in multiple jets, elliptical secondary-MR orifices, and dynamic MR. ACCACCClinical Trial
A prolapse-related EROA may emerge or increase in mid-to-late systole, whereas secondary MR may decrease during mid-systole; a holosystolic lesion has different quantitative implications. ACCACCClinical Trial
Track LV chamber size and systolic function longitudinally, but do not assume a single linear LV dimension captures remodeling; primary MR may preferentially remodel the apex and mid-cavity. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Degenerative disease
Route primary MR to durable repair when intervention is indicated
Repairability and center expertise are decisive in degenerative MR.
For severe symptomatic MR, surgical mitral repair is the preferred therapeutic option when degenerative anatomy has a high likelihood of successful repair; valve replacement is the alternative when intervention is indicated but repair is not feasible or durable. jaccjaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Refer patients being considered for mitral intervention through a multidisciplinary valve team that identifies lesion severity, the intended intervention, and the appropriate surgeon or operator. For degenerative disease amenable to repair, use a surgeon with dedicated mitral expertise and contemporary repair outcomes; referral to another center is appropriate when local repair expertise is insufficient. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
Use TEE-based segmental anatomy to distinguish lesions likely to support repair from those that may require replacement or transcatheter alternatives. The procedural plan should specify whether the valve is repairable before treatment selection, rather than treating all severe primary MR as interchangeable. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Favor repair over replacement when degenerative anatomy is repairable and intervention is required. jaccjaccThrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Do not determine candidacy from MR grade alone; document mechanism, repairability, ventricular response, symptoms, and procedural risk for Heart Team review. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
For patients evaluated for transcatheter treatment, obtain imaging adequate to define leaflet anatomy and procedural feasibility. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Heart failure pathway
Treat secondary MR as a heart failure and valve disease problem
Secondary MR management requires heart failure optimization and anatomic selection for intervention.
Secondary MR is common, increases with age, and is associated with excess mortality. Its treatment pathway should include a heart failure specialist because the valve lesion arises in the setting of LV disease and the expected benefit of intervention depends on patient phenotype. BMJ+1BMJGetting the best from the Heart Team: guidance for cardiac ...BMJBurden, treatment use, and outcome of secondary mitral ...
For patients with secondary MR being considered for intervention, perform Heart Team review after defining MR mechanism and severity, reviewing TTE and any CMR or other cross-sectional imaging, and determining the planned procedure. The multidisciplinary group should function as the entry point for patients under consideration for mitral intervention. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
TEER with MitraClip has randomized-trial evidence in selected patients with heart failure and secondary MR. COAPT was a multicenter randomized controlled trial of MitraClip in patients with heart failure and MR, and five-year follow-up reported lower rates of all hospitalizations and heart failure hospitalizations with transcatheter repair. NEJM+1NEJMFive-Year Follow-up after Transcatheter Repair ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ... Divergent results between COAPT and MITRA-FR reinforce that secondary-MR phenotyping and patient selection are central rather than optional. BMJ+2BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...Oxford AcademicRandomized controlled trials in valvular heart disease
Involve heart failure expertise before TEER selection for secondary MR. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
Use the same multidisciplinary review to determine severity, procedural suitability, and the operator or surgeon. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
Do not extrapolate TEER benefit to every secondary-MR phenotype; the contrasting MITRA-FR and COAPT results require individualized anatomic and clinical selection. BMJ+2BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...Oxford AcademicRandomized controlled trials in valvular heart disease
Interpreting trial differences
MITRA-FR reported a 54.6% primary-outcome rate, including 24.3% all-cause mortality and 48.7% unplanned hospitalization, while COAPT demonstrated benefit from MitraClip-based TEER in a selected heart failure population. These trials support referral for structured selection rather than a reflex procedural approach based solely on the presence of secondary MR. BMJ+2BMJthe Gulf MTEER registry (GULF Mitral Transcatheter Edge ...NEJMTranscatheter Mitral-Valve Repair in Patients with Heart ...Oxford AcademicThe management of secondary mitral regurgitation in patients ...
Follow-up
Monitor ventricular response and reassess when anatomy or physiology changes
Serial imaging should detect progression before irreversible remodeling narrows treatment options.
Follow LV chamber size and function longitudinally after MR is identified, because contemporary guidance uses LV dimensions and ejection fraction as intervention triggers in asymptomatic patients. Interpret serial change with awareness that one linear measurement may miss nonuniform remodeling, particularly in primary MR. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Use CMR or three-dimensional echocardiography selectively when TTE-derived quantification is limited by image quality, eccentric or multiple jets, or discordant ventricular remodeling. CMR offers more reproducible and accurate volumetric tracking than linear dimensions, although volumetric thresholds have not been established as guideline intervention triggers. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Re-refer for multidisciplinary review when serial TTE shows worsening MR, evolving LV size or function, new uncertainty about repairability, or a change in candidacy for surgical or transcatheter intervention. Imaging should be available for expert review before the intervention decision is finalized. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
Do not use CMR-derived LV volumes as a stand-alone intervention trigger; use them to resolve uncertainty and track change. BMJBMJImaging assessment of mitral and aortic regurgitation: current state of the art | Heart
Repeat expert imaging review when changing geometry alters the distinction between primary and secondary MR or changes repair/TEER feasibility. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartBMJGetting the best from the Heart Team: guidance for cardiac ...
For any planned intervention, document the mechanism, severity, imaging evidence, and procedural plan in the multidisciplinary assessment. BMJBMJGetting the best from the Heart Team: guidance for cardiac ...
Common questions
When should an apparent severe MR measurement be questioned?
Question a single severe or nonsevere quantitative value when jet geometry, timing, chamber response, and clinical status are discordant. PISA may underestimate secondary MR with an elliptical orifice or multiple jets; three-dimensional imaging can help but may overestimate EROA. BMJ+1BMJImaging assessment of mitral and aortic regurgitation: current state of the art | HeartACCClinical Trial
References
- Imaging assessment of mitral and aortic regurgitation: current state of the art | Heart — heart.bmj.com · heart.bmj.com
- Getting the best from the Heart Team: guidance for cardiac ... — heart.bmj.com · heart.bmj.com
- Secondary tricuspid valve regurgitation: a forgotten entity — heart.bmj.com · heart.bmj.com
- Shadows and light in transcatheter mitral valve treatment — heart.bmj.com · heart.bmj.com
- Burden, treatment use, and outcome of secondary mitral ... — www.bmj.com · www.bmj.com
- the Gulf MTEER registry (GULF Mitral Transcatheter Edge ... — bmjopen.bmj.com · bmjopen.bmj.com
- Five-Year Follow-up after Transcatheter Repair ... — www.nejm.org · www.nejm.org
- Transcatheter Mitral-Valve Repair in Patients with Heart ... — www.nejm.org · www.nejm.org
- Percutaneous Interventions for Secondary Mitral Regurgitation — www.ahajournals.org · www.ahajournals.org
- Quantitation of Mitral Regurgitation | Circulation — www.ahajournals.org · www.ahajournals.org
- Grading of Mitral Regurgitation by Quantitative Doppler ... — www.ahajournals.org · www.ahajournals.org
- Valvular Heart Disease in Circulation and the ... — www.ahajournals.org · www.ahajournals.org
- Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement — www.jacc.org · www.jacc.org
- Functional Mitral Regurgitation and the Role of ... — www.sciencedirect.com · www.sciencedirect.com
- Mitral valve disease—current management and future ... — www.sciencedirect.com · www.sciencedirect.com
- ACC/AHA and ESC/EACTS Guidelines for the ... — www.sciencedirect.com · www.sciencedirect.com
- Review Article Secondary Mitral Regurgitation — www.sciencedirect.com · www.sciencedirect.com
- MitraClip Versus Surgery for Secondary Mitral ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- European Journal of Heart Failure expert consensus ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- The management of secondary mitral regurgitation in patients ... — academic.oup.com · academic.oup.com
- Randomized controlled trials in valvular heart disease — academic.oup.com · academic.oup.com
- Comparison of Meta-Analytical Estimates Between Surgical ... — academic.oup.com · academic.oup.com
- Cardiac remodelling and clinical outcomes after mitral edge-to ... — academic.oup.com · academic.oup.com
- Clinical Trial — www.acc.org · www.acc.org